Original Article

You have full text access to this OnlineOpen article

Evaluation of shark cartilage in patients with advanced cancer†‡

A North Central Cancer Treatment Group trial

  1. Charles L. Loprinzi M.D.1,§,*,
  2. Ralph Levitt M.D.2,
  3. Debra L. Barton R.N., Ph.D.1,
  4. Jeff A. Sloan Ph.D.1,
  5. Pam J. Atherton M.S.1,
  6. Denise J. Smith1,
  7. Shaker R. Dakhil M.D.3,
  8. Dennis F. Moore Jr. M.D.3,
  9. James E. Krook M.D.4,
  10. Kendrith M. Rowland Jr. M.D.5,
  11. Miroslaw A. Mazurczak M.D.6,
  12. Alan R. Berg M.D.7,
  13. George P. Kim M.D.8

Article first published online: 23 MAY 2005

DOI: 10.1002/cncr.21107

Issue

Cancer

Cancer

Volume 104, Issue 1, pages 176–182, 1 July 2005

Additional Information

How to Cite

Loprinzi, C. L., Levitt, R., Barton, D. L., Sloan, J. A., Atherton, P. J., Smith, D. J., Dakhil, S. R., Moore, D. F., Krook, J. E., Rowland, K. M., Mazurczak, M. A., Berg, A. R. and Kim, G. P. (2005), Evaluation of shark cartilage in patients with advanced cancer. Cancer, 104: 176–182. doi: 10.1002/cncr.21107

Author Information

  1. 1

    Departments of Oncology and Biostatistics, Mayo Clinic and Mayo Foundation, Rochester, Minnesota

  2. 2

    Meritcare Hospital Community Clinical Oncology Program, Fargo, North Dakota

  3. 3

    Wichita Community Clinical Oncology Program, Wichita, Kansas

  4. 4

    Duluth Community Clinical Oncology Program, Duluth, Minnesota

  5. 5

    Carle Cancer Center Community Clinical Oncology Program, Urbana, Illinois

  6. 6

    Sioux Community Cancer Consortium, Sioux Falls, South Dakota

  7. 7

    Missouri Valley Cancer Consortium Community Clinical Oncology Program, Omaha, Nebraska

  8. 8

    Division of Hematology/Oncology, Mayo Clinic Jacksonville, Jacksonville, Florida

  1. §

    Fax: (507) 284-1803

*Mayo Clinic, 200 First Street SW, Rochester, MN 55905

  1. †

    This study was conducted as a collaborative trial of the North Central Cancer Treatment Group and Mayo Clinic and was supported in part by Public Health Service grants CA-25224, CA-37404, CA-35113, CA-63849, CA-63848, CA-35195, CA-35272, CA-35269, CA-35103, CA-35101, CA-60276, CA-52352, CA-37417, CA-35448.

  2. ‡

    Additional participating institutions include: CentraCare Clinic, St. Cloud, MN 56301 (Harold E. Windschitl, M.D.); Siouxland Hematology-Oncology Associates, Sioux City, IA 51105 (Donald Wender, M.D.) Iowa Oncology Research Association CCOP, Des Moines, IA 50314 (Roscoe F. Morton, M.D.); Toledo Community Hospital Oncology Program (Paul L. Schaefer, M.D.); Medcenter One Health Systems, Bismarck, ND 58506 (Edward J. Wos, D.O.); Cedar Rapids Oncology Project CCOP, Cedar Rapids, IA 52403 (Martin Wiesenfeld, M.D.); Meritcare Hospital CCOP, Fargo, ND 58122 (Preston Steen, M.D.)

Publication History

  1. Issue published online: 17 JUN 2005
  2. Article first published online: 23 MAY 2005
  3. Manuscript Accepted: 25 FEB 2005
  4. Manuscript Revised: 11 FEB 2005
  5. Manuscript Received: 28 OCT 2004

Funded by

  • Public Health Service. Grant Numbers: CA-25224, CA-37404, CA-35113, CA-63849, CA-63848, CA-35195, CA-35272, CA-35269, CA-35103, CA-35101, CA-60276, CA-52352, CA-37417, CA-35448

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (124K)

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Joan W. Young, Prakash Thapaliya, Santosh Sapkota, Caught in the Middle, International Journal of User-Driven Healthcare, 2011, 1, 1, 27

    CrossRef

  2. 2
    Kah Chang, Rachel Brodie, Mei Choong, Karl J Sweeney, Michael J Kerin, Complementary and alternative medicine use in oncology: A questionnaire survey of patients and health care professionals, BMC Cancer, 2011, 11, 1, 196

    CrossRef

  3. You have free access to this content3
    Paul Posadzki, Shark cartilage for cancer patients: a mini systematic review, Focus on Alternative and Complementary Therapies, 2011, 16, 3
    Direct Link:
  4. 4
    Hyun Cho, Jin-Yeong Yoo, Soo-Hee Park, A Literature Review of Clinical Trials on Alternative Medicine, Journal of the Korea Academia-Industrial cooperation Society, 2010, 11, 11, 4395

    CrossRef

  5. 5
    C. Lu, J. J. Lee, R. Komaki, R. S. Herbst, L. Feng, W. K. Evans, H. Choy, P. Desjardins, B. T. Esparaz, M. T. Truong, S. Saxman, J. Kelaghan, A. Bleyer, M. J. Fisch, Chemoradiotherapy With or Without AE-941 in Stage III Non-Small Cell Lung Cancer: A Randomized Phase III Trial, JNCI Journal of the National Cancer Institute, 2010, 102, 12, 859

    CrossRef

  6. 6
    Y. Sumiyoshi, K. Hashine, Y. Kakehi, K. Yoshimura, T. Satou, H. Kuruma, S. Namiki, N. Shinohara, Dietary Administration of Mushroom Mycelium Extracts in Patients with Early Stage Prostate Cancers Managed Expectantly: A Phase II Study, Japanese Journal of Clinical Oncology, 2010, 40, 10, 967

    CrossRef

  7. 7
    J. White, The Challenge of Rational Development of Complex Natural Products as Cancer Therapeutics, JNCI Journal of the National Cancer Institute, 2010, 102, 12, 834

    CrossRef

  8. 8
    Elvira Gonzalez Mejia, Vermont P. Dia, The role of nutraceutical proteins and peptides in apoptosis, angiogenesis, and metastasis of cancer cells, Cancer and Metastasis Reviews, 2010, 29, 3, 511

    CrossRef

  9. You have free access to this content9
    Thomas M. Habermann, Carrie A. Thompson, Betsy R. LaPlant, Brent A. Bauer, Carol A. Janney, Matthew M. Clark, Teresa A. Rummans, Matthew J. Maurer, Jeff A. Sloan, Susan M. Geyer, James R. Cerhan, Complementary and alternative medicine use among long-term lymphoma survivors: A pilot study, American Journal of Hematology, 2009, 84, 12
    Direct Link:
  10. 10
    Thomas Kalinski, Saadettin Sel, Irina Kouznetsova, Martin Röpke, Albert Roessner, Heterogeneity of angiogenesis and blood vessel maturation in cartilage tumors, Pathology - Research and Practice, 2009, 205, 5, 339

    CrossRef

  11. 11
    Barrie Cassileth, Jyothirmai Gubili, Palliative Medicine, 2009,

    CrossRef

  12. 12
    A. Munshi, L. H. Ni, M. S. Tiwana, Complementary and Alternative Medicine in Present Day Oncology Care: Promises and Pitfalls, Japanese Journal of Clinical Oncology, 2008, 38, 8, 512

    CrossRef

  13. 13
    Jeong Wook Kim, Complementary Therapies and Cancer Treatment, Journal of the Korean Medical Association, 2008, 51, 5, 427

    CrossRef

  14. 14
    Jun-Young Choi, Complementary Therapy for Improvement of Quality of Life in Cancer Patients, Journal of the Korean Medical Association, 2008, 51, 5, 435

    CrossRef

  15. 15
    Mary L. Hardy, Dietary Supplement Use in Cancer Care: Help or Harm, Hematology/Oncology Clinics of North America, 2008, 22, 4, 581

    CrossRef

  16. 16
    Dona E.C. Locke, Paul A. Decker, Jeff A. Sloan, Paul D. Brown, James F. Malec, Matthew M. Clark, Teresa A. Rummans, Karla V. Ballman, Paul L. Schaefer, Jan C. Buckner, Validation of Single-Item Linear Analog Scale Assessment of Quality of Life in Neuro-Oncology Patients, Journal of Pain and Symptom Management, 2007, 34, 6, 628

    CrossRef

  17. 17
    Pamela J. Atherton, Paul J. Novotny, Angelina D. Tan, Jeff A. Sloan, Analyzing the “Correct” Endpoint, Current Problems in Cancer, 2006, 30, 6, 283

    CrossRef

  18. 18
    Gerald M. Y. Quan, Peter F. M. Choong, Anti-angiogenic therapy for osteosarcoma, Cancer and Metastasis Reviews, 2006, 25, 4, 707

    CrossRef

  19. 19
    Denise J. Smith, Jef Huntington, Jeff A. Sloan, Choosing the “Correct” Assessment Tool, Current Problems in Cancer, 2006, 30, 6, 272

    CrossRef

  20. 20
    Jacqueline Filshie, Carolyn N.J. Rubens, Complementary and Alternative Medicine, Anesthesiology Clinics of North America, 2006, 24, 1, 81

    CrossRef

  21. 21
    J. Daniell Rackley, Peter E. Clark, M. Craig Hall, Complementary and Alternative Medicine for Advanced Prostate Cancer, Urologic Clinics of North America, 2006, 33, 2, 237

    CrossRef

  22. 22
    Amy P. Abernethy, Robert M. Arnold, PC-FACS:A Real-Time Evidence Resource for Busy Palliative Care Clinicians, Journal of Palliative Medicine, 2006, 9, 1, 24

    CrossRef

  23. 23
    Edzard Ernst, Why there will never be an alternative cancer cure, Anti-Cancer Drugs, 2006, 17, 9, 1023

    CrossRef

View Full Article (HTML) Get PDF (124K)